Company Alerts November 13, 2026 Vanderbilt Report: SecureTech’s AI UltraProd Lands Its First U.S. Build Site, Taking Robotic 3D-Printed Housing to California
Biotechnology Pharmaceutical November 11, 2026 Hepatitis Delta Phase 3 Results: Vir’s Elebsiran and Tobevibart Meet Primary Goal in ECLIPSE 1
Health November 11, 2026 Earlier Bedtime and Weight Loss: NYU Study Links Sleep Timing, Not Sleep Length, to Pounds Lost in Prediabetes
Energy World News November 10, 2026 COP31 Antalya Opens: Climate Finance Clash, 1.5°C Overshoot Warning and What to Watch as Leaders Arrive
AI & Machine Learning Cybersecurity November 10, 2026 Australia AI Safety Regulator: Albanese Announces Mandatory Safeguards After OpenAI Agent Breached Medicare Portal
Biotechnology Pharmaceutical November 11, 2026 Hepatitis Delta Phase 3 Results: Vir’s Elebsiran and Tobevibart Meet Primary Goal in ECLIPSE 1
Biotechnology Pharmaceutical November 4, 2026 Huntington’s Disease Gene Therapy AMT-130 Gets FDA Priority Review: The Science, the Evidence and What Comes Next
Biotechnology Pharmaceutical October 29, 2026 Petosemtamab Phase 3 Results: Genmab Head and Neck Cancer Drug Cuts Death Risk 50% With Keytruda
Biotechnology Pharmaceutical October 21, 2026 FDA Approves Hibsago: A New Chronic Hepatitis B Treatment Aims for a “Functional Cure”
Biotechnology Pharmaceutical October 14, 2026 Admilparant Phase 3 Results: BMS IPF Drug Meets Primary Goal at 60 mg, Misses at 120 mg
Biotechnology Health Pharmaceutical October 7, 2026 Vaxcyte VAX-31 Phase 3 Results: 31-Valent Pneumococcal Vaccine Meets All Primary Endpoints in OPUS-1
Biotechnology Pharmaceutical September 30, 2026 FDA Approves Emcitate, the First MCT8 Deficiency Treatment: The Science, the Evidence and What Comes Next
Biotechnology Editors Picks NYSE-NASDAQ Pharmaceutical September 23, 2026 Viking Therapeutics’ VK2735 Maintenance Data: Less Frequent Dosing Kept Most Weight Off
Newsroom Pharmaceutical June 24, 2026 Pharmaceutical News Today: FDA Wins, Big M&A, and a New Era of Drug Pricing
Health Pharmaceutical Top Stories Weekly Recap June 11, 2026 Pharmaceutical News: A Big Month of FDA Decisions and New Drug Firsts
Company Alerts November 13, 2026 Vanderbilt Report: SecureTech’s AI UltraProd Lands Its First U.S. Build Site, Taking Robotic 3D-Printed Housing to California
Biotechnology Pharmaceutical November 11, 2026 Hepatitis Delta Phase 3 Results: Vir’s Elebsiran and Tobevibart Meet Primary Goal in ECLIPSE 1
Health November 11, 2026 Earlier Bedtime and Weight Loss: NYU Study Links Sleep Timing, Not Sleep Length, to Pounds Lost in Prediabetes
Energy World News November 10, 2026 COP31 Antalya Opens: Climate Finance Clash, 1.5°C Overshoot Warning and What to Watch as Leaders Arrive